Loading clinical trials...
Loading clinical trials...
The LIFT+Biodesign® study is a post-market observational study to evaluate the rate of fistula closure in patients with persistent trans-sphincteric anal fistula who receive the Biodesign® Tissue graf...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Cook Group Incorporated
NCT06918808 · Perianal Fistula Due to Crohn's Disease
NCT05243966 · Abdominal Wound Dehiscence, Necrotizing Soft Tissue Infection, and more
NCT06798155 · Hemorrhoid, Anal Fistulas, and more
NCT05039411 · Perianal Fistula Due to Crohn's Disease, Fistula in Ano
NCT06803550 · Anal Fistula, Anal Fissure Chronic, and more
University of California Irvine
Orange, California
Rush University Medical Center
Chicago, Illinois
Indiana University Hospitals
Indianapolis, Indiana
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions